申请人:Hoffmann-La Roche Inc.
公开号:US11505573B2
公开(公告)日:2022-11-22
The present invention provides compounds of formula (I)
wherein X, L1 and R1 to R10 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments for the treatment of diseases and infections caused by Acinetobacter baumannii.
本发明提供了式 (I) 的化合物
其中 X、L1 和 R1 至 R10 如本文所述,以及其药学上可接受的盐类。此外,本发明还涉及式(I)化合物的制造、包含它们的药物组合物以及它们作为治疗鲍曼不动杆菌引起的疾病和感染的药物的用途。